CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

COMPREHENSIVE OFFERING OF LIQUID STABLE BIO-SYNTHETIC REFERENCE MATERIALS FOR URINE CHEMISTRIES NOW AVAILABLE FROM VERICHEM

VERICHEM now offers clinical laboratorians a comprehensive range of liquid stable and ready-to-use biosynthetic clinical reference materials designed for system calibration and calibration verification testing procedures with urine chemistry assays.

CluePoints Continues Impressive Global Growth with Three New Senior Appointments

CluePoints Continues Impressive Global Growth with Three New Senior Appointments The company welcomes new VP Marketing, VP People, and VP Business Operations to its expanding team King of Prussia, PA – 5th April, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations.

WCG Unveils Strategic Alliance Program for CROs

Leading CROs Increase Adoption of WCG's Suite of Solutions Enabling Connectivity to Top Clinical Trial Sites Via Unrivaled Technology and Staffing Solutions Global Program Drives Collaboration to Increase Efficiency and Reduce Burden on Investigative Sites, Accelerating Clinical Trials Sponsored by Pharmaceutical, Biotech and Medical Device Companies

Kyruus Welcomes Gail Airasian as General Manager of Emerging Markets as the Company Expands Its Platform to Serve the Broader Digital Health Market

Seasoned Healthcare Industry Executive Joins Organization to Lead Business Development, Acquisitions, and Expansion into New Markets

Rho Hires Global VP of Quality Assurance to Support International Expansion following Acquisition

Epic Selects Lyniate for Integration within the Epic Garden Plot Offering

Novel drug from Neuro-Bio effective in a mouse model of Alzheimer's Disease

Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease.

PubHive Integrates Unpaywall Into PubHive Navigator

Cloud software platform PubHive Navigator saves time for life science teams by expanding journal article access via the platform’s research literature workflow module Fetch

Alfa Chemistry Refreshed Its Website for the Supply of MOF Chemicals

Earlier this year, Alfa Chemistry, a well-established chemical supplier based in New York, announced its decision to further optimize its supply of MOF chemicals, a new material that has huge potentials in fields like gas storage, separation, and catalysis. Now the company has completed the website refresh work and introduced a new brand logo. All these efforts are made in the hope of bringing better customer experience and more convenient website searching.

CD Formulation Announces to Offer Nitrosamine Impurities Analysis Service for Drug Formulation Projects

Earlier this month, CD Formulation announces that it is now capable of providing nitrosamine impurities analysis service for customers who are involved with drug formulation projects and need help from CRO companies like CD Formulation.

Summarization of the POC Blood Gas and Electrolyte, including the initiatives undertaken by the organizations for its improvisation

Global POC Blood Gas and Electrolyte Market share accounted for up to US$1.95 Bn. It is predicted to reach approximately US$3.6 Bn by 2028, with a steady CAGR of 7.89% throughout the time frame of 2020-2028.

Insightful Science Bolsters Executive Team with Senior Sales and Marketing Expertise to Accelerate Growth Initiatives

Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV).

Zelis Announces New Chief Marketing Officer, Heather Valteris, International Brand Builder and Strategist for Fortune 100 Companies

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Creative Peptides Announces Innovative Services of Peptide Drug Discovery

Creative Peptides announces the release of innovative peptide drug discovery services to support and assist global clients in winning the race of peptide drug development.

Creative Peptides Rolls Out PNA FISH Probes with High Sensitivity and Specific Hybridization

Creative Peptides rolls out a variety of PNA FISH probe products with high sensitivity and specific hybridization for worldwide customers.

Useful Approaches for Labeling Peptides with Fluorescent Dyes

Creative Peptides provides useful approaches for labeling peptides with fluorescent dyes